Application and Effectiveness of the STEPPS in Patients With BPD, Extending to Their Families With the FC Program

January 5, 2024 updated by: Universitat Jaume I

Application and Analysis of the Effectiveness of the STEPPS Program in Patients With BPD, Extending to Their Families With the Family Connections Program: A Randomized Controlled Trial

The present research project is framed within the issue of Borderline Personality Disorder (BPD). This condition stands as one of the most common challenges encountered within the mental health services of the National Health System. The primary objectives of this research are to verify whether the combined use of established treatments for patients and their families, conducted in parallel, leads to a greater improvement in patients and their families, respectively. Additionally, another aim of the project is to assess efficiency, defined as the acceptance of intervention programs by patients, their families, and clinical professionals, as well as to demonstrate their feasibility.

Study Overview

Detailed Description

The literature so far seems to indicate that involving family members in psychotherapeutic interventions for patients diagnosed with Severe Mental Disorders (SMD) such as psychosis or bipolar disorder is effective, reducing hospitalizations and increasing treatment satisfaction. However, interventions with such characteristics have not been found for patients with Borderline Personality Disorder (BPD), one of the disorders included under the umbrella of SMD. Therefore, it seems necessary to develop and implement comprehensive programs involving families, given the benefits observed in other SMD diagnoses such as psychosis or bipolar disorder.

BPD is one of the personality disorders that receives significant clinical attention and research, with suicide being one of the most associated problems with this diagnosis, ranging from 3-10%. The prevalence of BPD in the general population is considered to be around 1%, rising to 12% in clinical populations and 22% in hospitalized patients. Meta-analysis studies place Linehan's Dialectical Behavior Therapy (DBT) and Bateman and Fonagy's Mentalization-Based Therapy as the two interventions with the highest level of recommendation. Another widely supported intervention is Blum's Systems Training for Emotional Predictability and Problem Solving (STEPPS) program, especially effective when delivered in a group format within clinical and hospital settings due to its high adaptability. However, the issues described concerning patients with BPD inevitably lead to severe consequences in their work, emotional, and social environments. Relatives of individuals with BPD are more likely to experience psychological problems, burden, and depression. Generally, when family members participate in treatments, the patient's relapses decrease, recovery becomes easier, and overall family well-being improves. Presently, interventions for relatives of patients with BPD exist. Family Connections (FC) has received the most empirical support. Nevertheless, to date, there have been no studies analyzing whether adding intervention programs for family members contributes to an improvement in the STEPPS program, which is precisely the aim of this current research. Specifically, the objective of this work is to compare the effectiveness of the STEPPS protocol for patients with BPD and their relatives, compared to the STEPPS protocol for patients alone and the Family Connections program for their relatives.

The Randomized Clinical Trial (RCT) will be conducted following the guidelines of the Consolidated Standards of Reporting Trials (CONSORT: http://www.consort-statement.org) and the SPIRIT guidelines (Standard Protocol Items: Recommendations for Intervention Trials). Participants (N=120) will be randomly assigned to two groups (after receiving a diagnosis of Borderline Personality Disorder according to the DSM-5): 1) STEPPS program for patients 2) STEPPS program for patients and Family Connections for their relatives. Participants in the second group may receive the Family Connections intervention for their relatives after completing the research evaluation period for ethical reasons. Outcome measures will be assessed at baseline, post-treatment, and at 6-month follow-ups.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Castellón de la Plana, Spain, 12071
        • Universitat Jaume I

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

PATIENTS

Inclusion Criteria:

  • Being at least 18 years old.
  • Be a patients with symptoms compatible with a diagnosis of BPD who is undergoing treatment or follow-up in someone of the indicated recruitment centers.
  • Sign an informed consent.

Exclusion Criteria:

  • The presence of any pathology that prevents carrying out the intervention: major depression, psychosis, schizophrenia, substance dependence, eating disorders, another personality disorder, borderline IQ, etc., which due to its severity is currently interfering.

FAMILIES:

Inclusion Criteria:

  • Being at least 18 years old.
  • Be a relative of someone of the patients with symptoms compatible with a diagnosis of BPD who is undergoing treatment or follow-up in someone of the indicated recruitment centers.
  • Sign an informed consent.

Exclusion Criteria:

  • The presence of any pathology that prevents carrying out the intervention: major depression, psychosis, schizophrenia, substance dependence, eating disorders, another personality disorder, borderline IQ, etc., which due to its severity is currently interfering.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: STEPPS for patients plus Family Connections for their families
Intervention group that receives STEPPS program for patients to carry out the intervention about BPD symptoms and in parallel another group that receives Family Connectios program for their families to carry out the intervention about associated symptoms.
The intervention will be based on cognitive and behavior treatment using STEPPS for the patients and dialectical and behavior treatment using Family Connections for the families. Main components STEPPS: psychoeducation, emotional regulation skills and behavioral regulation skills. Main components Family Connections: psychoeducation, skills training and peer support.
Active Comparator: STEPPS for patients only
Intervention group that receives STEPPS program for patients only to carry out the intervention about BPD symptoms.
The intervention will be based on cognitive and behavior treatment using STEPPS for the patients. Main components STEPPS: psychoeducation, emotional regulation skills and behavioral regulation skills. Waiting list group: Participant's relatives of this group will be able to receive the Family Connections intervention after the research end.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BDI: Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months
This questionnaire assesses the degree of depressive symptomatology in the last week. It consists of 21 items rated on a scale from 0 (nothing) to 3 (very much).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months
OASIS: Overall Anxiety Severity and Impairment Scale (OASIS; Norman, Cissell, Means-Christensen, & Stein, 2006). Adapted into Spanish by Osma et al. (2019).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months
This questionnaire assesses the degree of anxiety symptomatology in the last week. It consists of 5 items rated on a scale from 0 (mild) to 4 (extreme).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months
INQ: The Interpersonal Needs Questionnaire (INQ; Van Order et al., 2012). We will use the Spanish version by Marco & Pérez (2016).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the degree of interpersonal needs currently. It consists of 15 items rated on a scale from 1 (nothing true) to 7 (totally true).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
ACWRSS: The Acquired Capability with Rehearsal for Suicide Scale (ACWRSS; George et al., 2016). We will use the Spanish version by Marco et al. (2020).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the acquired capability with rehearsal for suicide. It consists of 7 items rated on a scale from 0 (disagreement) to 8 (agreement).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
DERS: Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2008). We will use the Spanish version by Hervás & Jódar (2008).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the ability to regulate emotions. It consists of 28 items rated on a scale from 1 (hardly never) to 5 (almost always).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
BSL-23: Borderline Symptom List 23 (BSL-23; Bohus et al., 2008). We will use the Spanish version by Feliú-Soler et al. (2012).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the degree of symptoms of borderline personality disorders in the last week. It consists of 23 items rated on a scale from 0 (never) to 4 (very much) and 11 items rated on a scale from 0 (nothing) to 4 (daily).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
QLI: Quality of Life Index (QLI; Ferrans & Powers, 1985). We will use the Spanish version by Mezzich et al. (2000).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the level of quality of life currently. It consists of 10 items rated on a scale from 1 (bad) to 10 (excellent).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
PIL-20: Purpose in Life-20 (PIL-20; Crumbaugh & Maholick, 1964).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the purpose in life. It consists of 20 items rated on a scale from 1 (nothing) to 7 (very much).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
VIRS: Validating and Invalidating Responses Scale (VIRS; Fruzzetti, 2007).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the degree of validated or invalidating responses from the family in the last week. It consists of 15 items rated on a scale from 0 (never) to 4 (almost every time).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
LEAP: Lum Emotional Availability of Parents (LEAP; Lum & Phares, 2005).
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the perception of emotional availability from the parents. It consists of 15 items rated on a scale from 0 to 6 about the father and 0 to 6 about the mother.
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
Registry of family-patient critical incidents in the last three months.
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
The registry consist of 6 questions about number of critical incidents such as suicide attempts or visits to the emergency room.
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BAS: Burden Assessment Scale (BAS; Reinhard et al., 1994). Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the level of disease burden in the last 6 months. It consists of 19 items rated on a scale from 1 (nothing) to 4 (very much).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
FES: Family Empowerment Scale (FES; Koren, DeChillo, & Friesen, 1992). Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the degree of perception of mastery and empowerment. It consists of 34 items rated on a scale from 1 (totally false) to 4 (totally true).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
DASS-21: Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & Lovibond, 1995). We will use the Spanish version by Bados, Solanas, & Andrés (2005). Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the degree of depression, anxiety and stress in the last week. It consists of 21 items rated on a scale from 0 (never) to 3 (very much).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
QLI: Quality of Life Index (QLI; Ferrans & Powers, 1985). We will use the Spanish version by Mezzich et al. (2000). Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the level of quality of life currently. It consists of 10 items rated on a scale from 1 (bad) to 10 (excellent).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
SVSI-Q: The Self-Validation and Self-Invalidation Questionnaire (SVSI-Q; Fruzzetti & Davis, in preparation). Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the degree of self-validation or self-invalidation. It consists of 24 items rated on a scale from 1 (hardly ever) to 5 (always).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
PIL-20: Purpose in Life-20 (PIL-20; Crumbaugh & Maholick, 1964). Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the purpose in life. It consists of 20 items rated on a scale from 1 (nothing) to 7 (very much).
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
Measurement of acceptance and satisfaction. Treatment Opinion Scale (adapted from Borkovec & Nave, 1972). Relatives's responses
Time Frame: immediately after treatment, also at follow-up assessment periods (6 months)
This questionnaire assesses the opinión about treatment at the end of the investigation. It consists of 7 items rated on a scale from 1 (nothing) to 7 (very much).
immediately after treatment, also at follow-up assessment periods (6 months)
Registry of family-patient critical incidents in the last three months. Relatives's responses
Time Frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
The registry consist of 6 questions about number of critical incidents such as suicide attempts or visits to the emergency room.
At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Soledad Quero, Psychology, Universidad Jaume I

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 2, 2024

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

December 22, 2023

First Submitted That Met QC Criteria

January 5, 2024

First Posted (Estimated)

January 8, 2024

Study Record Updates

Last Update Posted (Estimated)

January 8, 2024

Last Update Submitted That Met QC Criteria

January 5, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder (BPD)

Clinical Trials on STEPPS plus Family Connections

3
Subscribe